Disease progress in patients with Morbus Fabry after switching from agalsidase beta to agalsidase alpha

Intern Med J. 2014 Feb;44(2):205-7. doi: 10.1111/imj.12348.
No abstract available

Publication types

  • Letter

MeSH terms

  • Disease Progression
  • Drug Monitoring / methods
  • Drug Substitution / methods*
  • Echocardiography
  • Enzyme Replacement Therapy / methods
  • Fabry Disease / blood
  • Fabry Disease / diagnosis
  • Fabry Disease / drug therapy*
  • Fabry Disease / physiopathology
  • Glomerular Filtration Rate
  • Humans
  • Isoenzymes / administration & dosage*
  • Male
  • Treatment Outcome
  • alpha-Galactosidase / administration & dosage*

Substances

  • Isoenzymes
  • alpha-Galactosidase
  • agalsidase beta